IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway

Abstract

Epithelial-mesenchymal transition (EMT) is a key process in tumor metastatic cascade that is characterized by the loss of cell-cell junctions and cell polarity, resulting in the acquisition of migratory and invasive properties. However, the precise molecular events that initiate this complex EMT process in head and neck cancers are poorly understood. Increasing evidence suggests that tumor microenvironment plays an important role in promoting EMT in tumor cells. We have previously shown that head and neck tumors exhibit significantly higher Bcl-2 expression in tumor-associated endothelial cells and overexpression of Bcl-2 alone in tumor-associated endothelial cells was sufficient to enhance tumor metastasis of oral squamous cell carcinoma in a SCID mouse model. In this study, we show that endothelial cells expressing Bcl-2 (EC-Bcl-2), when co-cultured with head and neck tumor cells (CAL27), significantly enhance EMT-related changes in tumor cells predominantly by the secretion of IL-6. Treatment with recombinant IL-6 or stable IL-6 overexpression in CAL27 cells or immortalized oral epithelial cells (IOE) significantly induced the expression of mesenchymal marker, vimentin, while repressing E-cadherin expression via the JAK/STAT3/Snail signaling pathway. These EMT-related changes were further associated with enhanced tumor and IOE cell scattering and motility. STAT3 knock-down significantly reversed IL-6-mediated tumor and IOE cell motility by inhibiting FAK activation. Furthermore, tumor cells overexpressing IL-6 showed marked increase in lymph node and lung metastasis in a SCID mouse xenograft model. Taken together, these results demonstrate a novel function for IL-6 in mediating EMT in head and neck tumor cells and increasing their metastatic potential.

Areca nut exposure increases secretion of tumor‐promoting cytokines in gingival fibroblasts that trigger DNA damage in oral keratinocytes

“…IL‐8 is capable of promoting cancer progression by regulating angiogenesis through autocrine and paracrine mechanisms 28, 29. Autocrine effects of IL‐6 in tumorigenesis have been identified in human cancers such as prostatic,30 breast9 and head and neck cancer 31. Our finding which showed the proliferation of OSCC cells after cytokine treatment was in agreement with those studies (Fig.…”

Inactivation of the Transcription Factor GLI1 Accelerates Pancreatic Cancer Progression

“…These molecules modulate growth, proliferative, migration, and apoptotic pathways, often resulting in metastasis and advanced stage disease (33)(34)(35)(36)(37)(38)(39)(40). Next, we evaluated expression of a panel of cytokines associated with disease progression using pancreas tumor tissues from the same cohort in the previous section by qPCR.…”

Adipose tissue, obesity and adipokines: role in cancer promotion

“…Activation of these pathways can cause a spiraling cascade of cytokines that continually upregulate inflammatory responses and perpetuate an increased inflammatory state that can lead to a carcinogenic state [112,113]. The downstream pro-inflammatory cytokines produced activate specific pathways that lead to proliferation, differentiation and metastasis of the cancerous cells as seen by the activation of JAK/STAT and MAPK pathways via IL-6 that is upregulated by NF-kB [114]. PI3K and AKT phosphorylation are also induced by resistin and lead to the proliferation of cancer cells as demonstrated in several cancer cell lines [110].…”